Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 108
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How Do Fats Help Us Treat Brain Cancer?

    Malignant Brain Tumors will kill over 13,000 cancer patients this year in the United States alone; brain...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Help us pioneer stem cell therapy for giraffe!

    Arthritis is common in geriatric giraffe. Cheyenne Mountain Zoo is uniquely suited to help find better arthritis...

    Backer Badge Funded